Big Gain For KTRA

KTRA (KTRA:NASDAQ) rocketted at $1.02, a gain of 20%. The stock got featured on our News Catalysts scanner on Mon, Oct 11, 2021 at 09:39 AM in the 'MISCELLANEOUS' category. From Mon, Oct 04, 2021, the stock recorded 40.00% Up Days and 36.36% Green Days

The stock spiked on Wed, Oct 13, 2021 at $1.08 with a volume of 9M+.

About KTRA (KTRA:NASDAQ)

DelMar Pharmaceuticals Inc is a clinical and commercial-stage drug development company, which focuses on the research and development of drugs for the treatment of cancer. The company's principal product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in clinical trials stage for the treatment of refractory glioblastoma multiforme, a form of brain cancer. It also has a strategic collaboration with Guangxi Wuzhou Pharmaceutical for the development of VAL-083 used in treating chronic myelogenous leukemia and lung cancer. All the business activity of the firm is functioned through the region of Canada.